Adaptive Biotechnologies
ADPT
ADPT
230 hedge funds and large institutions have $4.8B invested in Adaptive Biotechnologies in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 98 increasing their positions, 60 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 248 → 230 (-18)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
32% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 56
Holders
230
Holding in Top 10
5
Calls
$17.2M
Puts
$6.32M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$53.8M | |
| 3 | +$52.2M | |
| 4 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$48.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$37.4M |
Top Sellers
| 1 | -$46.3M | |
| 2 | -$30.4M | |
| 3 | -$21.4M | |
| 4 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$19.8M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$13.4M |